Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Renee

05/29/20 4:55 PM

Post #1

Admedus Ltd. changed to Anteris Technologies Ltd.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Anteris Technologies Ltd. (AMEUF)

Followers	2	Posters	1
Posts (Today)	0	Posts (Total)	1
Created	01/04/15	Type	Free
Moderators

Admedus Corp. is the American arm of Australian ASX-listed Admedus Ltd – a diversified healthcare company focused on developing and commercializing next generation technologies with global potential. Specifically, Admedus is developing a new generation of tissue bio-implants that more easily integrate into recipient tissue, show less capacity for rejection and have the potential to replace many of the products that surgeons currently use. Our patented ADAPT™ tissue engineering process produces implantable biological scaffolds that more closely mimic the characteristics of normal human tissue. This promotes a more tolerant immune response with improved tissue in-growth. Tissue exposed to the ADAPT™ process has been shown to have significantly improved functionality and longer term durability of the resulting bio-implant. With the potential for a product lifespan free from calcification, clinicians may be able to intervene across a broader age spectrum and provide their patients with a solution for life.